Home > Journals > Minerva Surgery > Past Issues > Minerva Surgery 2023 December;78(6) > Minerva Surgery 2023 December;78(6):626-32

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Minerva Surgery 2023 December;78(6):626-32

DOI: 10.23736/S2724-5691.23.09876-3

Copyright © 2023 EDIZIONI MINERVA MEDICA

language: English

Basal cell adenoma and pleomorphic adenoma of the parotid gland: a single center experience

Chiara BIANCHINI 1, Marco BRUGALI 1, Andrea MIGLIORELLI 1, Virginia CORAZZI 1, Giovanni CAMMAROTO 2, Giuseppe MECCARIELLO 2, Francesco STOMEO 1, Andrea CIORBA 1 , Stefano PELUCCHI 1

1 Ear, Nose and Throat (ENT), and Audiology Unit, Department of Neurosciences, University Hospital of Ferrara, Ferrara, Italy; 2 Ear, Nose and Throat (ENT) Unit, Morgagni Pierantoni Hospital, AUSL Romagna, Forlì, Forlì-Cesena, Italy



BACKGROUND: Basal cell adenoma (BCA) and pleomorphic adenoma (PA) are among the most common benign neoplasms of the salivary glands. The aim of this study was to analyze and compare the diagnosis, treatment, and recurrence rate of these two different types of parotid benign tumors.
METHODS: A retrospective analysis of all cases of parotid gland BCA and PA surgically treated between January 1, 1990, and December 31, 2019, was performed at our university.
RESULTS: A total of 349 patients were enrolled in the present study, 311 of which (89.1%) were affected by PA, and 38 patients (10.9%) by BCA. The most frequently performed surgery was partial parotidectomy for both groups (85.9% in PA and 65.8% in BCA). Perioperative complications - often transient and of short duration - occurred within 48 hours of surgery and were observed in 30.6% of PA patients and in 18.4% of BCA patients; furthermore, recurrences were noticed in 19 PA patients (6.2%) and in 3 BCA patients (7.9%) (rates in range with the available literature data).
CONCLUSIONS: To the best of our knowledge, this study is one of the largest single-center series in the literature comparing diagnosis, treatment, recurrence rate and clinical-pathological features of two different types of benign parotid gland tumors, BCA, and PA.


KEY WORDS: Adenoma, pleomorphic; Salivary glands; Neoplasms; Parotid neoplasms

top of page